Member Info for share12345

WideCells Group is a Main Market listed healthcare services company focused on growing in the burgeoning market for stem cell services. Over the past few years, management have built up an integrated stem cell services provider, focused on providing products which make stem cell treatments accessible and affordable. Significant progress made in regulatory and commercial developments Following significant progress made since IPO in July 2016 and the launch of several products, WideCells is now on the cusp of rapid revenue growth. Across three divisions the company can now offer an end-to-end service via the storage and processing of umbilical cord blood and tissue, stem cell insurance, stem cell research work and training and learning for healthcare professionals and the general public. Stem cell markets growing rapidly A 2017 report from Transparency Market Research suggests that the total global market for stem cells is expected to grow at a CAGR of 13.8% from 2017 to 2025 to become worth $270.5 billion by 2025. Placing and bookbuild provide funds to accelerate growth WideCells has finalised a £1.871 million placing, including a £164,951 debt conversion, bringing the aggregate value to the group of the placing to £2.036 million gross. Net proceeds receivable will be approximately £1.641 million. The funds will provide the company with general working capital and the firepower to accelerate product development and roll-out across its three divisions. Indicative forecasts show huge growth potential WideCells has huge potential for growth over the coming years. Applying a 20% tax charge to our FY2020 forecast operating profits would put the shares on a price/earnings multiple of just 1.1 times. Recognising the early stage nature of the business, but considering the very low valuation should indicative forecasts be met, we initiate coverage of WideCells with a stance of Conviction Buy and initial price target of 12p representing a conservative 5 times multiple for 2020 reflecting the risks involved.

cheers

where the news.

30% drop in ten mins wow

looking good 2.29 paid

just need to hold .. let the sp do the work.. all good ..and the market will this this ..just need time for it to rerate

good rns people will be holing ther shares now.. up we go.. about time rerate

Chief Executive Officer of Bagir, Eran Itzhak, said "The desire from both companies to complete this transaction remains unchanged, meeting the requirements and the process associated with doing so has taken longer than first anticipated, however, both Ruyi and ourselves are confident we will complete this deal and that it will prove to be a valuable and productive partnership."

pop.

getting there.. lets clear 2.1

there must be a some one mopping this up keeps going nt.

need to get past 2.1

in Auction last ten mins ready to pop

mm being over load

off to a good start

here we go again..

see.. you still believe in Father Christmas and other myths. 25/12 is tthe date for you to note down.. news soon cos code 1 say so... lets get to 40% today ..would be nice..

OMG dont you believe in Father Christmas.

mm letting this go again nice to see this 40% today .. news must be soon ..

code 1 rns comiing inbound